Insights
Maine Explores On-Site Cannabis Consumption: A Leap Towards Inclusivity and Normalization
LOS ANGELES-Amid the serene backdrop of its pine-clad hills, Maine finds itself at the forefront of a significant legislative debate—one that could redefine the cannabis industry within its borders and potentially set a precedent for the nation. Lawmakers in the Pine Tree State are currently deliberating on a proposal that could introduce on-site cannabis consumption ...
Filament Health Corp. Gains FDA Approval for Psilocybin Clinical Trials
LOS ANGELES- The U.S. Food and Drug Administration (FDA) has recently granted an investigational new drug application to Vancouver-based Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) for its botanical psilocybin substance, PEX010. This approval marks a significant stride for Filament, enabling the firm to conduct clinical trials in the United States aimed at treating substance ...
Broad Support in Canada for Psilocybin Use in Palliative Care, New Study Reveals
LOS ANGELES — A recent Canadian study, published in the medical journal Palliative Medicine, has revealed significant public support for the use of psilocybin, a psychedelic compound, in treating existential dread among end-of-life patients. Conducted by a team led by Michel Dorval, a researcher at CHU de Québec-Université Laval Research Center and a professor at Université ...
FinCEN’s Corporate Transparency Act Has Arrived
NEW YORK- Enacted by Congress in 2021, the Corporate Transparency Act (CTA) went into effect on January 1, 2024 and affects more than 30 million American small businesses1 and many smaller foreign companies doing business in the United States. Unless exempted, these businesses must provide ownership information to the Treasury’s Financial Crimes Enforcement Network (FinCEN) ...
Organigram Advances in Cannabis Market with Strategic British American Tobacco Investment
LOS ANGELES- Organigram Holdings Inc., a significant player in the cannabis industry, has successfully closed the first tranche of a substantial investment from British American Tobacco's subsidiary, BT DE Investments Inc. This move marks a significant step in the Canadian company's expansion and diversification strategy. The first tranche involves the acquisition of 12,893,175 common shares ...
Ohio Cannabis Market Faces Challenges Amid Optimism for Adult-Use Expansion
LOS ANGELES- Ohio's medical cannabis market, one of the nation's most strictly regulated, showed signs of plateauing in 2023, with an increase of just 1.2% in annual sales compared to the previous year. This marks a significant slowdown from the explosive growth observed in the market's early years, according to a Crain’s Cleveland analysis. Despite ...
New Jersey Moves Forward with Cannabis Consumption Lounge Regulations
LOS ANGELES- The New Jersey Cannabis Regulatory Commission (CRC) is taking significant strides in the realm of cannabis consumption with the unanimous approval of regulations for consumption lounges, a pivotal development in the state's cannabis industry. The decision, made during a meeting on January 17, marks a progressive step towards actualizing these lounges in New ...
Revive Therapeutics Announces $3 Million Private Placement for Clinical and Operational Advancements
Revive Therapeutics Ltd. a prominent player in the biopharmaceutical sector, has recently announced its plan to initiate a significant private placement to fuel its ongoing and future projects. This strategic move, aimed at garnering up to $3 million in funding, represents a pivotal moment for the company's financial and clinical trajectory. Under the terms of ...
Indiana Residents Lean Toward Cannabis Legalization, New Poll Indicates
LOS ANGELES- As Indiana's legislators convene for a new session, the topic of cannabis legalization takes a prominent place in the agenda, bolstered by recent findings from the 2023 Hoosier Survey. Conducted by the Bowen Center for Public Affairs at Ball State University, the survey unveils a growing inclination among Indiana residents towards cannabis reform, ...
Study: Medical Cannabis Associated With Symptom Improvements In Patients With Major Depressive Disorder
ESSEN, Germany- A new study published in The Journal of Pharmacopsychiatry, reveals a link between the use of medical cannabis products and decreased levels of depression. German researchers investigated the use of medical cannabis in 59 outpatients diagnosed with major depressive disorder (MDD). While medical cannabis, including plant cannabis and cannabinoid treatments like dronabinol, became ...
AlphaFold: AI’s Role in the Future of Psychedelic Drug Development
LOS ANGELES- In the realm of pharmaceutical research, a groundbreaking approach is being adopted in the United Kingdom, where researchers are utilizing AlphaFold, an advanced artificial intelligence tool, to develop new psychedelic drugs potentially useful as antidepressants. The latest research, which awaits peer review, suggests that AlphaFold's AI-generated protein structures could rival traditional experimental methods ...
Pioneering the Future of Concussion Management: NFL and University of Regina Partner in Groundbreaking CBD Study
LOS ANGELES- In an era where concussion management is a paramount concern in sports, a revolutionary collaboration between the National Football League (NFL) and the University of Regina is making headlines. The partnership, aimed at exploring the potential of CBD in concussion treatment, marks a significant stride in athlete healthcare. The concern over concussions in ...
California’s Fiscal Challenge: Balancing Budget Deficit with Cannabis Tax Revenue Reallocation
LOS ANGELES- In the face of a significant $37.9 billion budget deficit, California Governor Gavin Newsom has proposed a contentious plan to reallocate funds from the state's cannabis tax revenue. This move has ignited debate over the state's fiscal priorities and the support for the cannabis industry. Governor Newsom's proposal involves redirecting $100 million from ...
Oregon Lawmakers Debate Reversing Drug Decriminalization
LOS ANGELES- In a significant shift in drug policy discussions, Oregon lawmakers from both major political parties are considering proposals to reverse aspects of the state's drug decriminalization, a move that has sparked debate and criticism from various advocacy groups. Last week, Republican lawmakers in the Oregon House put forward a proposal aiming to re-criminalize ...
New Jersey Sets Ground Rules for Cannabis Consumption Lounges
NEW YORK- The New Jersey Cannabis Regulatory Commission has recently taken a significant step in the cannabis industry by approving a set of rules for marijuana consumption lounges. This development marks a new business model within the Garden State, albeit with several key aspects still to be determined. As reported by NJBiz.com, while the regulatory ...
Ukraine’s Path to Medical Cannabis Industry
KYIV – Ukraine's Parliament has recently taken a groundbreaking step by approving a draft law to establish a medical cannabis industry, marking a significant shift in the nation's healthcare and economic landscape. However, industry experts predict that it may take years for domestic cannabis cultivation to become operational. The draft law, which is awaiting President Volodymyr ...
FDA Endorses Historic Shift in Cannabis Classification to Schedule III
LOS ANGELES- In a landmark development, the U.S. Food and Drug Administration (FDA) has advocated for a significant reclassification of cannabis under the Controlled Substances Act (CSA). The agency proposed that cannabis be moved from Schedule I to Schedule III, marking a transformative moment in the legal status and research potential of this substance. This ...
Exploring Cannabinoids in the Battle Against COVID-19: A Comprehensive Review
LOS ANGELES- In the ongoing quest to understand and combat COVID-19, a recent study titled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” presents intriguing possibilities offered by cannabinoids. Authored by researchers Cassidy Scott, Stefan Hall, Juan Zhou, and Christian Lehmann, the review meticulously examines the potential role of cannabis plant ...
Filament Health Achieves Milestone with First Botanical Psilocybin Export to Australia
NEW YORK – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS), a trailblazer in the realm of natural psychedelic drug development, announced a significant milestone in its global expansion with the successful export of PEX010, its botanical psilocybin drug candidate, to Perth, Western Australia. This shipment, received by Reset Mind Sciences Ltd., a subsidiary ...
Pentagon Responds to Rising Overdose Deaths with New Drug Policy Initiatives
LOS ANGELES- In an unprecedented move, the Department of Defense is set to implement a new policy in 2024 to address the escalating issue of drug overdoses within the United States military. This initiative, prompted by a surge in such incidents, involves two key components: tracking military overdoses and providing naloxone, commonly known as NARCAN, ...
Exploring Cannabinoids as a Potential Treatment Avenue for COVID-19 and Long-COVID
LOS ANGELES- In a groundbreaking development in the ongoing battle against COVID-19, a team of Canadian researchers has presented a comprehensive review that suggests a potential therapeutic role for cannabinoids. The study, entitled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” published in the Journal of Clinical Medicine, delves into how ...
California Cannabis Regulators Issue Health-Related Recalls on Products
LOS ANGELES- In a statement released on Wednesday, the DCC outlined the details of two separate recalls involving cannabis products. The recalls underscore ongoing regulatory vigilance in the burgeoning cannabis industry, particularly in California, a state at the forefront of cannabis legalization and regulation. California’s Department of Cannabis Control (DCC) has recently initiated mandatory and ...
New York Cannabis Control Board Approves Two More Operators for Recreational Market
NEW YORK — In a remarkably swift meeting on Friday, the New York Cannabis Control Board (CCB) made a significant decision, approving the transition of two additional multi-state operators (MSOs) from the medical to the recreational cannabis market. This move brings the total number of transitioning MSOs to eight, marking a notable expansion in New ...
Maine’s Cannabis Market Hits Record Highs
LOS ANGELES- The cannabis industry in Maine achieved a remarkable milestone in 2023, with retail revenues surpassing $200 million, despite a challenging backdrop of declining prices that have troubled operators. This surge represents a significant leap from the previous year, marking a 36% increase in sales and a notable upturn in consumer transactions. As reported ...
VA to Explore Psychedelics for PTSD and Depression
LOS ANGELES- In a groundbreaking move, the Department of Veterans Affairs (VA) is funding research into the therapeutic potential of psychedelics for treating mental health conditions like post-traumatic stress disorder (PTSD) and depression in veterans. This initiative, a first in decades, signals a significant shift in the VA's approach to mental health treatment. The VA's ...
